Showing 151-160 of 4063 results for "".
Ophthalmic Executives Provide Company Updates (Part 1 of 2)
https://modernod.com/podcasts/eyewire-news-the-podcast/ophthalmic-executives-provide-company-updates-part-1-of-2/37057/We hear from executives representing pharma and device manufacturers in the anterior segment who provide updates on their companies’ recently launched products and those in development.Case Studies in Treating Ocular Surface Disease: Season 2
https://modernod.com/podcasts/the-mod-pod/case-studies-in-treating-ocular-surface-disease-season-2-1/36805/Chris Starr, MD leads a new expert panel of Preeya Gupta, MD; Douglas DeVries, OD; and Leslie O’Dell, OD, as they deliberate on a myriad of interesting cases across the ocular surface spectrum.Vision Screening and US Population Health, Part 2: What You Need to Know
https://modernod.com/mod-issues/2022-mar/vision-screening-and-us-population-health-part-2-what-you-need-to-know/38390/A deeper dive into accessing care and why comprehensive eye examinations remain the best approach to improving population health.Visionary Breakthroughs: A Spotlight on Innovations in Eye Care (Part 1 of 2)
https://modernod.com/podcasts/eyewire-news-the-podcast/visionary-breakthroughs-a-spotlight-on-innovations-in-eye-care-part-1-of-2/39872/Industry executives discuss future innovations and breakthroughs that are poised to reshape the future of ophthalmic care. Learn more about your ad choices. Visit megaphone.fm/adchoicesPart 2: Contact Lens Business in The COVID-19 Era: Products on the Market
https://modernod.com/podcasts/the-mod-pod/part-2-contact-lens-business-in-the-covid-19-era-products-on-the-market/36797/The conclusion of our two-part special episode of The MOD Pod – Contact Lens Business in the COVID-19 Era: Products on the Market. Listen to Jeffrey Lewis, OD; Anith Pillai, OD, FSLS; Jennifer Tsai, OD; and Jessica Yu, OD, FAAO, discuss advancements and best practices when fitting scleral lenses andClinical Case Compendium: A Journey Through Detection, Treatment Initiation, and 2 Years of Active Complement Inhibition
https://modernod.com/resources/geographic-atrophy-case-compendium/a-journey-through-detection-treatment-initiation-and-2-years-of-active-complement-inhibition/39245/87. Cornea Chronicles Part 2: Managing Corneal Diseases ft. Dr. Sophia Leung
https://modernod.com/podcasts/four-eyes/87-cornea-chronicles-part-2-managing-corneal-diseases-ft-dr-sophia-leung/37037/Part two of our conversation with Dr. Sophia Leung takes a clinical turn as she shares her top tips for managing corneal diseases and dystrophies in primary care practice. We discuss red flags to watch for, when to treat versus refer, and practical advice for navigating complex corneal cases. If youPart 2: Contact Lens Business and Patient Safety in The COVID-19 Era: Redefining Normal
https://modernod.com/podcasts/the-mod-pod/part-2-contact-lens-business-and-patient-safety-in-the-covid-19-era-redefining-normal/36785/The conclusion of our two-part special episode of The MOD Pod – Contact Lens Business and Patient Safety in the COVID-19 Era: Redefining Normal. Listen to Rachael Wruble, OD, FAAO, speak with colleagues Brianna Rhue, OD, FAAO; William To, OD; and Justin Weigel, OD, about how they navigated the immedUsing Evidence in Clinical Care to Improve Patient Outcomes
https://modernod.com/topics/business/using-evidence-in-clinical-care-to-improve-patient-outcomes-1/38158/Part 2 of this series reviews how to recognize high-quality evidence and apply it in the clinical setting.Modern Management Of Vitreous Opacities: Acquiring History And Performing A Thorough Clinical Examination
https://modernod.com/mod-issues/supplements-inserts/modern-management-of-vitreous-opacities-acquiring-history-and-performing-a-thorough-clinical-examination/38359/Part 1 of 2